세계의 스파이로미터 시장 : 제품, 기술, 용도, 최종사용자별, 예측(2024-2032년)

Spirometer Market size is likely to record more than 9.6% CAGR from 2024 and 2032 propelled by the increasing prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. As per WHO, COPD claims the lives of over 3 million individuals annually. With rising global awareness about the importance of early detection and management of respiratory conditions, healthcare providers are increasingly adopting spirometers as essential diagnostic tools. Moreover, the aging population worldwide is contributing to the market growth, as elderly individuals are more prone to respiratory ailments and require regular monitoring of the lung functions.

Furthermore, the growing emphasis on preventive healthcare and wellness initiatives is fostering the adoption of spirometry testing as a routine screening tool in various healthcare settings. The integration of spirometry into telemedicine platforms and electronic health records facilitates remote monitoring and data management for enhancing patient care and treatment outcomes. Government initiatives and healthcare policies aimed at improving respiratory healthcare infrastructure and promoting early disease detection will also help in driving the market growth.

The spirometer industry is classified based on product, technology, application, end-use and region.

By application, the market size from the pulmonary fibrosis segment will record a 9.7% growth rate through 2032. Early detection and monitoring of pulmonary function are crucial for managing the rising prevalence of pulmonary fibrosis effectively. Spirometry serves as a vital diagnostic tool for assessing lung functions and monitoring disease progression in pulmonary fibrosis patients. With growing awareness about the importance of regular pulmonary function testing in disease management, the demand for spirometers among healthcare providers specializing in respiratory care will continue to rise.

In terms of end-use, the spirometer market from the homecare settings segment is poised to generate substantial revenue at 10% CAGR during 2024 and 2032. The growth is favored by the increasing emphasis on remote patient monitoring and management of chronic respiratory conditions in the comfort of the homes of patients. The convenience and accessibility offered by portable and user-friendly spirometers enables patients to perform lung function tests conveniently without the need for frequent visits to healthcare facilities.

Asia Pacific spirometers industry size will grow at 11.4% CAGR through 2032. The rapid urbanization and industrialization is leading to increasing levels of air pollution and the subsequent rise in respiratory diseases. The aging population in many Asian countries, coupled with changing lifestyles and dietary habits is contributing to a higher prevalence COPD and asthma. Additionally, government initiatives aimed at improving healthcare infrastructure and raising awareness about respiratory health will stimulate the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of respiratory diseases
    • 3.2.1.2 Technological advancements in devices
    • 3.2.1.3 Growing preference for home healthcare
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of skilled professionals and reimbursement policies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Reimbursement scenario
• 3.7 Porter's analysis
  • 3.7.1 Supplier power
  • 3.7.2 Buyer power
  • 3.7.3 Threat of new entrants
  • 3.7.4 Threat of substitutes
  • 3.7.5 Industry rivalry
• 3.8 PESTEL analysis
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Devices
  • 5.2.1 Hand held
  • 5.2.2 Table top
  • 5.2.3 Desktop
• 5.3 Software
• 5.4 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Volume measurement
• 6.3 Flow measurement
• 6.4 Peak flow meters

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Asthma
• 7.3 COPD
• 7.4 Cystic fibrosis
• 7.5 Pulmonary fibrosis
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Homecare settings
• 8.4 Clinical laboratories
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 COSMED srl
• 10.2 FUKUDA SANGYO CO., LTD.
• 10.3 Geratherm Medical AG
• 10.4 Hill-Rom Holdings, Inc. (Baxter International)
• 10.5 Koninklijke Philips N.V.
• 10.6 ndd Medical Technologies
• 10.7 Schiller AG
• 10.8 Sibelmed
• 10.9 Teleflex Incorporated
• 10.10 Vitalograph
• 10.11 Vyaire Medical Inc.